Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymogen

Glu-Trp, EW dipeptide, Oglufanide, L-Glutamyl-L-tryptophan

A synthetic dipeptide that modulates the immune system by enhancing T-cell differentiation, cytokine production, and overall immune response.

Quick Stats
Studies 94
Trials 51
Formula C16H19N3O5
Clear All
Utility 3
pubmed 2008

Oral absorption enhancement of dipeptide L-Glu-L-Trp-OH by lipid and glycosyl conjugation.

Bergeon. Julie A JA; Chan. Yiu-Ngok YN; Charles. Bruce G BG; Toth. Istvan I

Scientists attached fatty‑acid or sugar groups to the thymic peptide L‑Glu‑L‑Trp (thymogen) and found the modified versions are far less broken down by enzymes, cross gut‑cell models much better, and show higher absorption in rats, all without harming red blood cells.

Utility 3
pubmed 1997

[A clinical and experimental validation of the use of Stimuloss in patients with chronic generalized periodontitis].

Fedosenko. T D TD; Vladimirova. L G LG; Ivasenko. I N IN

A study tested a sponge containing hydroxyapatite, an antibacterial agent, and the peptide thymogen on gum disease. In lab tests, hydroxyapatite boosted bone‑cell activity and adding thymogen didn’t stop this effect. In 66 people with chronic periodontitis, the sponge reduced inflammation and helped regrow and strengthen the jaw bone.

Utility 3
pubmed 1990

[The immunocorrective therapy of pyoderma caused by staphylococci multiply resistant to antibiotics].

Rodionov. A N AN; Khavinson. V Kh VKh; Barbinov. V V VV

The study found that a synthetic thymus extract called thymogen can boost certain immune cells (T‑lymphocytes) in people with stubborn Staph skin infections, and that this boost was linked to the bacteria becoming less resistant to antibiotics. After a treatment course, some patients showed fewer resistant bugs and better immune markers, especially when thymogen was used together with antibiotics.

Utility 3
pubmed 1994

[Changes of immune and non-specific reactivity in patients with chronic suppurative obstructive bronchitis in comprehensive treatment with thymogen].

Litvinova. N V NV; Eremeev. V V VV; Abramova. Z P ZP; Kulikovskaia. N V NV; Gergert. V Ia VIa

A small clinical trial (33 people) with chronic bronchial infection showed that adding the peptide thymogen to a broader treatment plan helped normalize several immune markers, like T‑cell activity and natural killer cell function, and led to better overall clinical outcomes.

Utility 3
pubmed 1996

[Thymogen in the treatment of type-1 diabetes mellitus].

Zhuk. E A EA; Galenok. V A VA

A study gave the peptide thymogen to people with type‑1 diabetes who also had weakened immune systems. Most participants showed clinical improvement (about 94%) and lab markers of immune function improved in about 83%. The authors suggest a dosing schedule, but details are sparse.

Utility 3
pubmed Jul 26, 2016

Chemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating Activity.

Deigin. Vladislav V; Ksenofontova. Olga O; Khrushchev. Alexey A; Yatskin. Oleg O; Goryacheva. Alexan...

Researchers created a new chemical method to turn short peptide drugs like thymogen (Glu‑Trp) into pills that can be taken by mouth. They made five versions of the drug, and three of them boosted blood‑forming activity in mice and in bone‑marrow cells taken from irradiated mice. This shows the concept works, but it’s still early‑stage animal work.

Utility 3
pubmed Jan 19, 2017

Effects of tryptophan-containing peptides on angiotensin-converting enzyme activity and vessel tone ex vivo and in vivo.

Khedr. Sherif S; Deussen. Andreas A; Kopaliani. Irakli I; Zatschler. Birgit B; Martin. Melanie M

A study found that short protein fragments containing the amino acid tryptophan—especially the pair isoleucine‑tryptophan (IW)—can block the enzyme that raises blood pressure (ACE) and stop blood vessels from tightening up in lab cells and in hypertensive rats. The rats that ate IW showed better blood‑vessel relaxation, suggesting the peptide might help keep blood pressure and vascular health in check.

Utility 3
pubmed 1997

Natural and synthetic thymic peptides as therapeutics for immune dysfunction.

Morozov. V G VG; Khavinson. V K VK

Thymalin (a natural thymic peptide mix) and Thymogen (a synthetic dipeptide) both boost immune cell activity, like T‑cell maturation and cytokine release, and Thymogen also enhances neutrophil movement and eating of pathogens. They were tested in people with chronic illnesses and immune problems, showing they can help regulate inflammation, though natural and synthetic versions act slightly differently.

Utility 3
pubmed May 6, 2024

The First Reciprocal Activities of Chiral Peptide Pharmaceuticals: Thymogen and Thymodepressin, as Examples.

Deigin. Vladislav V; Linkova. Natalia N; Vinogradova. Julia J; Vinogradov. Dmitrii D; Polyakova. Vic...

The paper explains that the same two‑amino‑acid peptide can have opposite effects on the immune system depending on its handedness: the natural L‑form (Thymogen) boosts immunity, while the mirror‑image D‑form (Thymodepressin) dampens it. This shows that flipping a peptide’s chirality can switch it from a stimulant to a suppressor, opening the door to custom‑designed immune‑modulating peptides.

Utility 2
pubmed 1994

[The anti-arrhythmia properties of thymogen].

Reznikov. K M KM; Vinokurova. O V OV; Alabovskiĭ. V V VV; Vinokurov. A A AA

The study found that thymogen can help prevent irregular heartbeats and reduce harmful heart tissue changes in several lab models that mimic different types of arrhythmia. It looked at how different doses work and started to explore how it might act in the body, but the research was done in experimental settings, not in people.

Utility 2
pubmed Mar 31, 2009

Synthetic and natural immunomodulators acting as interferon inducers.

Silin. Dmytro S DS; Lyubomska. Oksana V OV; Ershov. Feliks I FI; Frolov. Valeriy M VM; Kutsyna. Galy...

The paper is a review that lists many drugs, including thymogen, that boost the body’s own interferon production. These compounds have been used for decades in former socialist countries for immune‑support, antiviral, anti‑cancer and anti‑inflammatory purposes, but they’re largely unknown in the West. No specific dosing or new efficacy data are given, so the information is mainly a heads‑up that such products exist.

Utility 2
pubmed Nov 1, 2004

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.

Deplanque. G G; Madhusudan. S S; Jones. P H PH; Wellmann. S S; Christodoulos. K K; Talbot. D C DC; G...

A small study gave the peptide IM862 (a dipeptide) to 25 people with advanced kidney cancer. It was safe and lowered a blood factor (VEGF) that helps blood vessels grow, but it didn’t shrink tumors or extend life meaningfully, so it isn’t useful as a stand‑alone cancer treatment at the tested dose.

Utility 2
pubmed 2000

[Immunomodulating activity of thymogen in acute pancreatitis].

Saĭdakhmedova. Z T ZT

In a small study of people with acute pancreatitis, giving the peptide thymogen (0.5‑0.8 mg) as part of their treatment helped restore T‑cell immune function and was linked to better clinical outcomes.